RESEARCH TRIANGLE PARK, N.C., Sept. 15, 2015 /PRNewswire/ -- Cloud Pharmaceuticals, Inc., a cloud-based drug design and development company, is pleased to share its partnering and presentation schedule for fall 2015. Representatives of the company will be in attendance to discuss Cloud Pharmaceuticals' unique value proposition and the market opportunities its approach to drug design and development represents.
Cloud Pharmaceuticals applies its Quantum Molecular DesignSM process to design drug candidates that are qualified for development from the outset, enabling faster progress at lower cost and a higher success rate. This process amplifies the power of cloud computing, quantum mechanics, and molecular property simulation to radically improve drug discovery and design. The company partners at all stages of drug development – from discovery through the clinic – and is building an extensive product pipeline that spans a wide range of indications. Upcoming partnering and presentation sessions include:
CED Tech Venture Conference
September 15-16, 2015
Redefining Early Stage Investments (RESI) Conference
September 16, 2015
BioPharm America 2015
September 15-17, 2015
BARDA Industry Day
October 14-16, 2015
BIO Investor Forum
October 20-21, 2015
CEO Ed Addison is to showcase Cloud Pharmaceuticals' pipeline, R&D activities, business objectives, and investment goals during a company presentation.
Partnering for Cures
November 1-3, 2015
Southeast BIO (SEBIO) Investor & Partnering Forum
November 11-13, 2015
New England Venture Summit
December 9, 2015
CEO Ed Addison will provide an overview of Cloud Pharmaceuticals' pipeline, R&D activities, business objectives, and investment goals during a company presentation.
To meet a member of Cloud Pharmaceuticals' team at an upcoming event, please visit the company's events page for contact information.
About Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals is a leader in the computational design of new drugs and subsequent rapid, information-driven drug development. We accelerate the drug discovery and design process in a way that delivers tangible results and true value for our partners. For information visit www.cloudpharmaceuticals.com.
Available Topic Expert: Ed Addison
For information on the listed expert, click appropriate link.
SOURCE Cloud Pharmaceuticals, Inc.